BWXT Medical is committed to communicating and engaging with the communities in which it operates in a timely, transparent and meaningful way.
Indigenous Relations
Click here to learn more about BWXT's progress, commitment and policy on Indigenous Relations.
Public Disclosure Protocol
BWXT Medical has a Public Disclosure Protocol with the objectives of providing information on the licensed activities to persons living near the site, fostering public awareness and providing channels for community members to share issues and concerns related to our licensed facilities.
The Public Disclosure Protocol is available as a PDF here.
The Public Disclosure Protocol describes how BWXT Medical communicates with its target audience. Based on this protocol, BWXT Medical commits to:
- Consulting with stakeholders to determine the type of information, and method for information sharing regarding this Public Disclosure Protocol;
- Maintaining two-way communication channels with the target audience to understand and address comments, questions and concerns;
- Providing reporting on its website within 48 hours of unusual operational events with the potential for offsite consequences;
- Providing timely reporting on its website within 48 hours of environmental events that trigger notification of the CNSC under Section 29 of the General Nuclear Safety and Control Regulations;
- Providing information to the target audience through BWXT Medical’s website and/or other Public Information Program activities, about significant operational changes or expansions that require an environmental assessment or amendments to the facility licence;
- Posting environmental monitoring results (relevant sections of Annual Compliance Reports) on its website;
- Posting any transport incidents reportable under the CNSC Packaging & Transport of Nuclear Substances Regulations;
- Posting planned and unplanned significant interruptions of facility operations resulting in significant disruption of customer isotope supply;
- Posting this Public Disclosure Protocol on the BWXT Medical website.
Any proposed changes to the Public Disclosure Protocol are reviewed and approved prior to implementation.
BWXT Medical’s Public Disclosure protocol does not prescribe the release of sensitive information, such as security related information and trade secrets or scientific, technical, commercial, financial or labour relations information.
Public Disclosures:
- 2023 – Minor damages to packages during transport. In 2023, there were four (4) instances of damaged packages during transportation. In all cases the damage was minor, with no impact to the integrity of radioactive product. There was no impact to health, safety or the environment.
- November 22, 2023 - Evacuation and False Alarm at Ottawa Facility, 447 March Road
- October 4, 2023 - Alarm condition at Ottawa Facility, 447 March Road
- September 6, 2023 - Evacuation and False Alarm at Ottawa Facility, 447 March Road
- Feb 9, 2023 - Transportation Incident
- January 24, 2023 - Ottawa Fire Services Facility Familiarization Visit
- January 17, 2023 - Ottawa Fire Services Facility Familiarization Visit
- January 10, 2023 - Ottawa Fire Services Facility Familiarization Visit
- 2022 – Minor damages to packages during transport In 2022, there were three (3) instances of damaged packages during transportation to customers. In all cases the damage was minor, with no impact to the integrity of the radioactive product. There was no impact to health, safety or the environment.
Type A packages containing Y-90 were damaged during transport on the following dates: - May 23, 2022: package damaged within the United States
- August 9, 2022: package damaged within Canada
- October 5, 2022: packaged damaged within the United States
- November 2, 2022 - Transportation Incident
- September 5, 2022 - Evacuation and False Alarm at Ottawa Facility, 447 March Road
- May 16, 2022 - Evacuation and False Alarm at Ottawa Facility, 447 March Road
- October 15, 2021 - CNSC's Record of Decision - Class IB Licence Issued
Environment
Environmental reports will continue to be added as they become available.
View BWXT Medical's Environmental Risk Assessment here.
Safety & Compliance
Frequently Asked Questions (FAQs)
As questions are received from the community, we will add them to our FAQ!
Submit a question by emailing us at isotopequestions@bwxt.com.
Community Newsletters
Community newsletters are a tool we use to share information with the local community that surrounds our Kanata facility. We try to keep our neighbours informed on our operational performance, health and safety, activities in the community and other general information. Electronic copies of newsletters will be added below as they become available.
Community Webinar
On Wednesday, March 31st, BWXT Medical hosted a webinar for the community to provide an overview of the Kanata operations and the licence application to the Canadian Nuclear Safety Commission (CNSC). If you have questions related to the content of this webinar, please contact us: isotopequestions@bwxt.com.
To watch the webinar, click here.
Community Giving & Volunteerism
At BWXT, we believe that healthy communities are strong communities and we take great pride in giving back. Through BWXT Volunteer Strong, our employees have the opportunity to help build stronger communities for those that live and work in them by volunteering time and expertise to local causes that are important to the Kanata community.
Did you know? On July 30th, 2021 we celebrated our three-year anniversary in the Kanata community!
If you would like to talk to us about an opportunity, please contact us at isotopequestions@bwxt.com.
CNSC Licence
BWXT Medical submitted an application on December 17, 2018 to the Canadian Nuclear Safety Commission (CNSC) to request issuance of its own Class IB Licence.
On October 15, 2021, the CNSC issued a news release on its Record of Decision for BWXT Medical's Class IB Licence application. The news release can be viewed here. The licence is valid until October 31, 2031.
CNSC Licence Documentation:
- CNSC Licence Application
- BWXT Medical Hearing Submission (CMD)
- CNSC Staff Recommendation (CMD)
- Licence Application Briefing Guide
- BWXT Medical Hearing Presentation
- CNSC Record of Decision (News Release)
Contact us at isotopequestions@bwxt.com or 1.833.657.4565 if you have questions, comments or concerns.